Literature DB >> 18560420

Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.

Takashi Nakamura1, Rumiko Moriguchi, Kentaro Kogure, Nilabh Shastri, Hideyoshi Harashima.   

Abstract

Recently, much attention has been paid to cell-penetrating peptides (CPPs) as an antigen-delivery tool for presentation through the major histocompatibility complex class I (MHC-I) pathway. However, escape of CPPs from the endosome is inefficient and therefore a bottleneck for antigen delivery. Previously, we showed the importance of topological control of octaarginine (R8) peptides on the liposome surface for regulating cellular uptake as well as intracellular trafficking, especially endosomal escape. In this study, we hypothesized that efficient MHC-I presentation could be achieved by controlled intracellular trafficking of antigen encapsulated in R8-modified liposomes (R8-Lip). The mechanism of uptake of both R8-Lip and cationic liposomes was shown to be by macropinocytosis in dendritic cells. However, confocal laser scanning microscopy (CLSM) revealed that R8-Lip are able to release significantly more antigen to the cytosol than are cationic liposomes. Processing of the antigens delivered by R8-Lip was shown to be proteasome-dependent, which is consistent with selective antigen presentation by R8-Lip via MHC-I. According to antigen-presentation analysis, R8-Lip can induce significantly higher MHC-I presentation at lower doses than either soluble ovalbumin (OVA) or OVA in pH-sensitive or cationic liposomes. Moreover, R8-Lip showed an efficient antitumor effect in vivo. Therefore, R8-Lip is a promising new carrier for MHC-I-specific antigen presentation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560420     DOI: 10.1038/mt.2008.122

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  24 in total

Review 1.  Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

Authors:  Ayman El-Sayed; Shiroh Futaki; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-01-06       Impact factor: 4.009

2.  Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.

Authors:  Fang Wu; Sherry A Wuensch; Mitra Azadniv; Mohammad R Ebrahimkhani; I Nicholas Crispe
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

Review 3.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

Review 4.  Nanotechnology: Future of Oncotherapy.

Authors:  Kshipra M Gharpure; Sherry Y Wu; Chun Li; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Clin Cancer Res       Date:  2015-07-15       Impact factor: 12.531

Review 5.  Biomaterials for nanoparticle vaccine delivery systems.

Authors:  Preety Sahdev; Lukasz J Ochyl; James J Moon
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

6.  The pH-sensitive fusogenic 3-methyl-glutarylated hyperbranched poly(glycidol)-conjugated liposome induces antigen-specific cellular and humoral immunity.

Authors:  Takehisa Hebishima; Eiji Yuba; Kenji Kono; Shin-Nosuke Takeshima; Yoshihiro Ito; Yoko Aida
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

Review 7.  Self-assembling peptide-based building blocks in medical applications.

Authors:  Handan Acar; Samanvaya Srivastava; Eun Ji Chung; Mathew R Schnorenberg; John C Barrett; James L LaBelle; Matthew Tirrell
Journal:  Adv Drug Deliv Rev       Date:  2016-08-14       Impact factor: 15.470

8.  A microbial glycolipid functions as a new class of target antigen for delayed-type hypersensitivity.

Authors:  Takaya Komori; Takashi Nakamura; Isamu Matsunaga; Daisuke Morita; Yuki Hattori; Hirotaka Kuwata; Nagatoshi Fujiwara; Kenji Hiromatsu; Hideyoshi Harashima; Masahiko Sugita
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

9.  Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.

Authors:  Naoya Miura; Hidetaka Akita; Naho Tateshita; Takashi Nakamura; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

Review 10.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.